ASA: Revenue up, losses deepen on impairment; further funding needed amid going concern risk

About this update from Atlantic Sapphire Asa

Revenue doubled to USD 43.3m in 2025 with improved biological performance and premium pricing, but net loss widened to USD 191.2m due to a USD 115.3m impairment. Additional capital is needed in 2026, with material uncertainty regarding going concern.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Atlantic Sapphire Asa